CVS HEALTH CORP (CVS) Stock Institutional Trading Activity


CVS HEALTH CORP (CVS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Hancock Classic Value, Ariel Appreciation Fund, Olstein Capital Management, Cullen Value Fund, and Tweedy, Browne Co All Funds (US). Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2024Turtle Creek Asset ManagementSell-56,4902,097,667$131,901,301
Q3 2024Hancock Classic ValueBuy198,92013,135,308$825,948,167
Q3 2024Sound Shore ManagementSell-25,0191,140,812$71,734,258
Q3 2024Cullen Value FundSell-1,06030,174$1,897,318
Q2 2024Ariel Appreciation FundBuy62,475669,084$39,516,101
Q2 2024Dodge & Cox Stock FundBuy20,670,80061,683,343$3,643,018,238
Q2 2024Olstein Capital ManagementBuy26,000155,000$9,154
Q2 2024Matrix Private Capital GroupSell-10813,113$774,454
Q2 2024Matrix Advisors Value FundSell-265,18318,561$1,096,000
Q2 2024Sequoia Financial AdvisorsSell-8,42031,967$1,887,999
Q2 2024Hillman Value FundBuy10,291124,329$7,342,860
Q2 2024Turtle Creek Asset ManagementBuy436,8912,154,157$127,224,512
Q2 2024Hancock Classic ValueBuy7,382,93112,936,388$764,023,075
Q2 2024Sound Shore ManagementSell-154,6621,165,831$68,853,979
Q2 2024Cullen Value FundSell-5,76731,234$1,844,700
Q1 2024Ariel Appreciation FundBuy490,715606,609$48,383,134
Q1 2024Dodge & Cox Stock FundBuy10,599,15341,012,543$3,271,160,430
Q1 2024Olstein Capital ManagementSell-13,000129,000$10,289
Q1 2024Matrix Private Capital GroupSell-29413,221$1,054,507
Q1 2024Sequoia Financial AdvisorsSell-249,84540,387$3,221,274
Q1 2024Hillman Value FundBuy376114,038$9,095,645
Q1 2024Matrix Advisors Value FundSell-7,410283,744$22,631,421
Q1 2024Turtle Creek Asset ManagementBuy15,6661,717,266$136,969,136
Q1 2024Hancock Classic ValueBuy4,729,2075,553,457$442,943,731
Q1 2024Cullen Value FundSell-5,06137,001$2,731,419
Q4 2023Dodge & Cox Stock FundBuy3,690,40830,413,390$2,401,441,274
Q4 2023Olstein Capital ManagementSell-13,000142,000$11,212
Q4 2023Renaissance Technologies LLCSell-797,500628,353$49,615
Q4 2023Matrix Private Capital GroupSell-10013,515$1,067,144
Q4 2023Scion Asset ManagementSell-35,00065,000$5,132,400

Frequently asked questions about CVS activity

  • Which institutional owners are buying CVS?

    Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CVS activity?

    "Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CVS increasing?

    Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.